ROHKEA: Virtual Reality Therapy 12-week Programme for Chronic Pain
Launched by TORBAY AND SOUTH DEVON NHS FOUNDATION TRUST · Dec 23, 2024
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The ROHKEA trial is exploring the use of Virtual Reality (VR) therapy to help people who suffer from chronic musculoskeletal pain, like low back pain. This 12-week program aims to provide a new way for patients to manage their pain from the comfort of their own homes. By using VR, participants can practice important skills to help them cope with their pain and gain the confidence to engage in daily activities, even when they are in discomfort. The study will involve six patients who will share their experiences and learnings through interviews and diaries during the program.
To be eligible for this trial, participants need to be adults aged 18 to 99 who have been experiencing chronic pain for at least three months. They must be comfortable using VR equipment and have access to a smartphone and Wi-Fi. Participants should also be willing to practice for about 30 minutes each day and be open to learning new techniques for managing their pain. Throughout the program, participants will receive support and guidance, and their feedback will help researchers understand the effectiveness of this innovative therapy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 18-99 years old
- • Willing and able to give informed consent
- • Experience chronic pain (minimum pain chronicity 3 months)
- • Able to use Virtual Reality equipment and satisfy the VR screening form stipulations
- • Have access to a smart phone (as need to use the mobile APP) and wifi
- • Willing to commit to up to 30minutes home practice a day
- • Willing to learn new skills and adopt a self management approach to manage their pain
- Exclusion Criteria:
- • Anyone aged less than 18years or over 99 years old
- • Unwilling and unable to give informed consent
- • Pain less than 3 months
- • Unable to use Virtual Reality equipment and do not satisfy the VR screening form stipulations
- • Do not have access to a smart phone or wifi
- • Are unwilling to commit to up to 30 minutes home practice each day
- • Unwilling to learn new skills and adopt a self management approach to manage their pain
About Torbay And South Devon Nhs Foundation Trust
Torbay and South Devon NHS Foundation Trust is a leading healthcare provider in the UK, dedicated to delivering high-quality patient care and advancing medical research through clinical trials. Committed to innovation and excellence, the Trust integrates research into its clinical practice, fostering an environment that supports the development of new treatments and therapies. With a focus on patient safety and ethical standards, Torbay and South Devon NHS Foundation Trust collaborates with various stakeholders to enhance healthcare outcomes and contribute to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Torquay, Devon, United Kingdom
Patients applied
Trial Officials
Phillipa Newton Cross
Principal Investigator
Torbay and South Devon NHS FT
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported